IIT-M develops a lab-on-a-chip diagnostic device
A team led by Prof. Ashis Kumar Sen, the corresponding
author of the paper from the Department of Mechanical Engineering, IIT
Madras, used a 2-cm-long microchannel device that employs capillary
force to draw blood into the device to separate plasma from whole blood
and test glucose level in diabetic patients.
The
first part of the microchannel device has hydrophilic walls (top and two
side walls) that help the blood sample to be drawn in through capillary
force. But one centimetre away, all the four walls of the microchannel
are hydrophobic. Like a drop of water on a Teflon surface, the blood
comes together and forms a large contact angle (more than 90 degrees)
when it enters the hydrophobic region. The forward movement of the blood
is suddenly impeded and the blood cells tend to accumulate in the
hydrophobic region of the microchannel.
Unlike blood
cells, the plasma with its low viscosity continues to move forward due
to the momentum gained while passing through the hydrophilic region.
“The blood cells slow down and then stop moving at the hydrophobic
region and form a self built-in filter, while the plasma continues to
move past the cells,” says Prof. Sen. “By creating a differential
wetting behaviour in the microchannel we were able to separate the
plasma from the blood cells.” Separating the plasma from blood cells is
essential as it improves sensitivity and reliability. Most blood
analyses are based on optical detection techniques, and the blood cells
present tend to interfere with the optical path resulting in low
sensitivity.
The device does not require any external
or internal power as it relies on capillary force to draw blood and the
separation of plasma from blood cells is achieved through differential
wetting behaviour of the microchannel walls.
“Only
5 microlitre of blood is required and in 15 minutes we get 450
nanolitre of plasma which further increases with time. With suitable
design modifications we have also achieved higher plasma volume up to 2
microlitre in 15 min, which is adequate for detection of most analytes,”
says M. Sneha Maria, the first author of the paper from the Department
of Mechanical Engineering and Department of Biotechnology, IIT Madras.
It takes 15-20 minutes to test the samples and get the results.
The
detection platform for different diseases and conditions can be
integrated within the device inside the hydrophobic region. “This is a
proof-of-concept study so we used commercially available glucose test
strips to detect glucose level in the blood samples,” says Maria. The
sensitivity of the disposable device is comparable to conventional blood
tests, says Prof. Sen.
Unlike the microchannel
device used by the IIT team, commercial glucometers rely on whole blood
for testing. Using whole blood can cause measurement errors due to
various hematocrit levels (the ratio of the volume of red cells to the
volume of whole blood). When the hematocrit levels are high the
viscosity of blood is more and this leads to low glucose concentration
and underestimation. Overestimation results when the hematocrit levels
are low. “There is a likelihood of more than 10 per cent error in
glucose detection when whole blood is used,” says Maria.
The
team is now testing the device for diagnosis of dengue. Currently,
rapid diagnostic test kits (RDTs) either use whole blood which affects
the sensitivity or centrifuged plasma for dengue detection. This is
where the device can score over others.
Prof. Sen is
hopeful that the device can be used for parallel detection of analytes
for several diseases using just one blood sample. “We intend to separate
the plasma to multiple detection sites for studying several diseases in
one go,” he says.
No comments:
Post a Comment